ZBIO

ProShares UltraPro Short NASDAQ Biotechnology
ZBIO

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ZBIO was delisted on the 27th of March, 2020.

Back to rankings

6 hedge funds and large institutions have $701K invested in ProShares UltraPro Short NASDAQ Biotechnology in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
$155K
Net Calls
Net Calls Change

Top Buyers

1
+$176K
2
+$11.5K
3
+$1K

Top Sellers

1
-$85.2K
2
-$36.3K
3
-$18K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$297K
2
$176K
3
$169K
4
$55K
5
$3K
6
$1K